Eurosurveillance banner


Call for papers for a special issue on molecular epidemiology of human pathogens

Follow Eurosurveillance on Twitter: @Eurosurveillanc


Eurosurveillance Quartely Q4 2009


In this issue:
Canadian study shows increasing levels of cross-reactive antibodies to a swine influenza A(H3N2) virus in children under 10 but an unexpected decreasing pattern in adults between 20 and 59


Eurosurveillance, Volume 17, Issue 4, 26 January 2012

Table of Contents

Rapid communications

Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010
Outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli O104:H4 among French tourists returning from Turkey, September 2011
Two invasive mosquito species, Aedes albopictus and Aedes japonicus japonicus, trapped in south-west Germany, July to August 2011
Perspectives

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe
Miscellaneous

In the national epidemiological bulletins - a selection from current issues
Job vacancy at the European Centre for Disease Prevention and Control

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2007-2011. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.